GSEA results revealed that SUSD3 is closely linked to immune activation processes, acting as a positive regulator of several key pathways, including IRE1-mediated unfolded protein responses, amebiasis, and proteoglycan pathways in cancer. Here, SUSD3 is linked to cancer.